Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Aug 2024 for YIELD10 BIOSCIENCE, INC., €1,199.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kristi Snell: trading record in brief
This profile gathers the share dealings of Kristi Snell in Yield10 Bioscience, Inc., where the filings describe the role as board member. Over a trading history stretching from 1 April 2017 to 15 August 2024, the count stands at 13 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 20 August 2024 with a share grant (€1,199) in Yield10 Bioscience, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kristi Snell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
877 shares@ US$1.501.7% of flowCommon StockSEC:0001628280-24-037879:0
120,000 shares@ US$0.3048.3% of flowCommon StockSEC:0001628280-24-005491:0
1,177 shares@ US$3.595.7% of flowCommon StockSEC:0001687986-23-000005:0
988 shares@ US$2.683.7% of flowCommon StockSEC:0001104659-22-089862:0
418 shares@ US$4.252.4% of flowCommon StockSEC:0001104659-22-030198:0
6,733 shares@ US$3.8333.5% of flowCommon StockSEC:0001179110-22-001145:0
351 shares@ US$6.713.0% of flowCommon StockSEC:0001179110-21-008612:0
7 of 7 declarations
